21 May, 2024 Endovascular shunting for communicating hydrocephalus using a biologically inspired transdural cerebrospinal fluid valved eShunt® implant Admin2025-08-05T19:58:32+00:00May 21st, 2024|Tags: Neurosurgery Clinics of North America| Read More
13 May, 2024 CereVasc Announces $70 Million Series B Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus Admin2024-05-28T21:41:18+00:00May 13th, 2024| Read More
07 May, 2024 CereVasc Receives FDA IDE Approval for the STRIDE Pivotal Study of the eShunt System for Treatment of Normal Pressure Hydrocephalus cerevasc2024-05-28T21:43:24+00:00May 7th, 2024| Read More
